Board of Directors
Mr. Abramovitz was appointed as a director of our Company on February 27, 2016. Mr. Abramovitz has held managerial positions in various organizations (Israeli companies and charities) including acting as deputy CEO of A.S. Mehadrin Ltd. Mr. Abramovitz holds a B.A.
Mrs. Ronit Even-Zahav Meitin is a certified accountant in Israel and holds a BA in Accounting and Economics from Tel Aviv University and an MBA in Finance from Bar Ilan University, Israel. Since 2014, Mrs. Even-Zahav Meitin has provided financial consulting services to various companies, including
Mr. Ostrovitzky was appointed as a director of our Company on December 5, 2013. Since 2008 he has acted as the President of Ostrovitzky Holdings Company, a company which has developed a variety of real estate projects in the Czech Republic, Germany, and Israel. As President, Mr.
Mr. Schlisser was appointed as a director of our Company on February 27, 2016. Mr. Schlisser holds managerial positions in various investment firms and has experience in mergers and acquisitions transactions in the healthcare, cleantech, and FinTech industries as well as in real estate and
Mr. Alon Shalev holds an MS in Solid State Electronics, Physical Electronics (cum laude) and a BS in Electrical Engineering both from Tel Aviv University. Mr. Shalev led BrainsGate from its inception phase, into its European clinical trials with a highly innovative technological and clinical
Dr. Weiss, currently serves as Vice President, Medical Affairs and Clinical Development of Juniper Pharmaceuticals Inc. He was previously Global Medical Director of Women’s Health and Bone Health at Teva Pharmaceutical Industries, Ltd. Dr. Weiss received an MBA from the George Washington